Pregnancy loss occurs in about 15% of clinically recognized pregnancies, and defective maternal-fetal immune tolerance contributes to more than 50% of these events. We found that signaling by the type I membrane protein T cell immunoglobulin and mucin-containing protein 3 (Tim-3) in natural killer (NK) cells had an essential protective role during early pregnancy. Tim-3 on peripheral NK (pNK) cells was transiently increased in abundance during the first trimester of pregnancy, which depended on interleukin-4 (IL-4)-signal transducer and activator of transcription 6 (STAT6) and progesterone signaling. Tim-3 + pNK cells displayed immunosuppressive activities, including the production of anti-inflammatory cytokines and the induction of regulatory T cells (T regs ) in a transforming growth factor-b1 (TGF-b1)-dependent manner. Tim-3 on pNK cells was stimulated by its ligand galectin-9 (Gal-9), leading to signaling by the kinases c-Jun N-terminal kinase (JNK) and AKT. In recurrent miscarriage (RM) patients, Tim-3 abundance on pNK cells was reduced and the immunosuppressive activity of Tim-3 + pNK cells was impaired. Compared to Tim-3 + pNK cells from donors with normal pregnancies, RM patient Tim-3 + pNK cells exhibited changes in DNA accessibility in certain genetic loci, which were reversed by inhibiting accessible chromatin reader proteins. Furthermore, Tim-3 + pNK cells, but not Tim-3 − pNK cells, reduced fetal loss in abortionprone and NK cell-deficient mice. Together, our findings reveal a critical role for Tim-3-Gal-9 signaling-mediated immunoregulation by pNK cells in maternal-fetal immune tolerance and suggest that Tim-3 abundance on pNK cells is a potential biomarker for RM diagnosis.
INTRODUCTION
How the semiallogeneic fetus can develop without being attacked or rejected by the maternal immune system has been a fascinating question in reproductive biology and immunology. Complex immunoregulation is required for maternal immune tolerance toward the semiallogeneic fetus and the maintenance of pregnancy (1, 2) . Once maternal-fetal immune tolerance is disturbed, various complications of pregnancy occur (3, 4) . Spontaneous abortion is the most common complication of gestation, occurring in about 15% of human pregnancies (5) . When a spontaneous abortion occurs, the risk of subsequent miscarriage is markedly increased. Recurrent miscarriage (RM) is defined as two or more consecutive miscarriages. More than 50% of these events remain unexplained after standard investigations (6) . There is also no reliable predictor or effective prevention strategy for RM. A systematic review and meta-analysis demonstrated that the most commonly used biomarkers [serum human chorionic gonadotropin (hCG) and progesterone] are not useful in predicting pregnancy outcome (7) . Therefore, an accurate diagnostic biomarker to predict miscarriage is urgently needed.
Multiple mechanisms for evading the rejection of embryos by the maternal immune system have been proposed (8) (9) (10) . As a critical regulator of active immune tolerance, inducible regulatory T cells (iT regs ) express the transcription factor Foxp3 and increase in number in the peripheral blood and decidua during pregnancy, playing indispensable roles in the generation of maternal-fetal tolerance in mice and humans (11, 12) . Natural killer (NK) cells with a high functional diversity have many regulatory roles in pregnancy. Although much attention has been paid to studying decidual NK (dNK) cells in pregnancy because of their marked abundance (13) (14) (15) , NK cells in the peripheral blood (pNK) may also play indispensable roles in pregnancy. These cells participate in increasing the number of T helper 2 (T H 2) cells while decreasing the number of T H 1 cells during gestation (16, 17) . In addition, an increased proportion of CD56 + CD16
+ NK cells is found in women with recurrent pregnancy loss, which is accompanied by an increase in the cytotoxic activity of pNK cells (18) (19) (20) . Nevertheless, the precise role of pNK cells during normal pregnancy (NP) and their regulatory mechanisms remain poorly understood.
T cell immunoglobulin and mucin-containing protein 3 (Tim-3), a type I membrane protein, was initially identified on terminally differentiated T H 1 cells. The identification of galectin-9 (Gal-9) as a ligand for Tim-3 has now firmly established the Gal-9-Tim-3 interaction as an important regulator of T H 1 immunity by inducing T H 1 cell apoptosis (21, 22) . Tim-3 is also found on T H 17 and T cytotoxic 1 cells. Tim-3 acts as a negative regulatory molecule to suppress cell-mediated immune responses and promote immune tolerance (23) (24) (25) . The engagement of Tim-3 by Gal-9 suppresses allograft rejection and improves the survival of allogeneic skin grafts (26) . Because embryos express paternal antigens, NP is often regarded as a successful allogeneic transplantation. In this regard, it is tempting to explore whether Gal-9-Tim-3 signaling plays a role in protecting the fetus from being attacked by the maternal immune system.
In addition to being found on T cells, Tim-3 is also found on innate immune cells, including mast cells, macrophages, dendritic cells (DCs), and NK cells (23, 25, 27) . Tim-3 not only serves as a marker of cellular activation or maturation but also suppresses NK cell cytotoxicity (28) . An increase in the cell surface abundance of Tim-3 on NK cells leads to NK cell dysfunction during chronic viral infections (29, 30) . Therefore, Tim-3 exerts diverse regulatory effects on NK cells under different immune contexts, involving numerous pathological and physiological processes. Whether Tim-3-mediated NK cell functions influence maternal-fetal immune tolerance and pregnancy outcome is currently unclear.
Here, we investigated the role of Tim-3 on pNK cells during early pregnancy in mice. We found that Tim-3 + NK cells proliferate in the first trimester through signaling by interleukin-4 (IL-4) and signal transducer and activator of transcription 6 (STAT6) or by progesterone signaling. Tim-3 + NK cells displayed tolerant phenotypes and induced the differentiation of naïve CD4 + T cells into iT regs in a transforming growth factor-b1 (TGF-b1)-dependent manner. Furthermore, in patients with RM, NK cells had reduced cell surface expression of Tim-3, and Tim-3 + NK cells produced less anti-inflammatory cytokines and lost their ability to induce iT reg generation. A loss of the suppressive activity of Tim-3 + NK cells in RM was associated with a global change in chromatin accessibility, which was partially reversed by the inhibition of accessible chromatin reader proteins. In abortion-prone (AP) or NK cell-deficient mice, the adoptive transfer of Tim-3 + NK cells reduced fetal loss, whereas the transfer of Tim-3 − NK cells had no effect. Our data suggest that the Gal-9-Tim-3 axis plays a role in the maintenance of NP through the regulation of pNK cell functions, suggesting that Tim-3 + pNK cells might be a promising biomarker for the prediction of RM.
RESULTS

Tim-3
+ NK cells are transiently increased in number in peripheral blood during early human pregnancy To characterize Tim-3 function in maternal-fetal immune tolerance, we first analyzed the expression of Tim-3 in peripheral blood mononuclear cells (PBMCs) during pregnancy. Leukocytes, NK cells, CD11c + DCs, and CD14
+ monocytes all showed a substantial cell surface abundance of Tim-3 ( fig. S1, A and B) . Although DCs and monocytes expressed Tim-3, the percentages of these cell populations that were Tim-3 did not vary during pregnancy ( fig. S1C ). In contrast, the percentage of Tim-3 + NK cells in the first trimester of pregnancy was considerably greater than that in either nonpregnant donors or those in the second trimester (Fig. 1, A (Fig. 1C) . Together, these data suggest that the number of Tim-3 + NK cells is transiently increased in the peripheral blood during the first trimester of pregnancy, a critical period for establishing maternal immune tolerance to the fetus.
+ NK cells display immunosuppressive activity during pregnancy To further investigate the role of Tim-3 + NK cells in human pregnancy, we analyzed the cytokines that they produce. Compared to Tim-3 − NK cells, Tim-3 + NK cells produced more anti-inflammatory cytokines, including TGF-b1, IL-10, and IL-4, but less of the pro-inflammatory tumor necrosis factor-a (TNF-a) (Fig. 1, D and E) . The abundance of perforin (Fig. 1E ) and the extent of cytotoxicity against HTR-8/SVneo cells (a first trimester human trophoblast cell line) (Fig. 1F) were also substantially reduced in Tim-3 + NK cells compared to Tim-3 − NK cells. Similar findings were obtained from a comparison of the abundances of the mRNAs encoding these cytokines between these two subpopulations of NK cells (Fig. 1G) . These results suggest that Tim-3 + NK cells have a robust immunosuppressive activity, which was further confirmed by microarray analysis (Fig. 1, H and I) . A gene ontology (GO) analysis revealed that cytokines and cytokine activity represented a major transcriptional difference between Tim-3 + and Tim-3 − pNK cells in early pregnancy ( fig. S2 ). These data suggest that Tim-3 + pNK cells have a high capacity to produce anti-inflammatory cytokines and a diminished cytotoxicity toward trophoblasts. These traits are conducive to an immune tolerant microenvironment.
The cell surface abundance of Tim-3 on NK cells is enhanced through IL-4-STAT6 or progesterone signaling We next investigated the factors that contributed to the increased abundance of Tim-3 on NK cells in early pregnancy. Because of the predominance of T H 2 over T H 1 cytokines during normal gestation (31, 32), we treated pNK cells with the T H 2 cytokine IL-4 and found that Tim-3 abundance was substantially increased (Fig. 2A) . Treatment with the T H 1 cytokine IFN-g reduced the abundance of Tim-3 under both basal and IL-4-stimulated conditions ( Fig. 2A) . Moreover, IL-4 activity was dependent on its downstream transcription factor STAT6, because a STAT6 inhibitor (A77-1726) abrogated the increased Tim-3 abundance induced by IL-4 ( Fig. 2 , B and C). We also observed the potential regulatory effects of pregnancy-associated hormones on Tim-3 abundance on NK cells. Progesterone exerted a biphasic regulatory effect on Tim-3 abundance, which depended on its concentration (Fig. 2D ). Progesterone at concentrations of 0.01 to 1.0 nM increased the abundance of Tim-3 on pNK cells in a dosedependent manner, whereas greater concentrations of progesterone (>100 nM) had an inhibitory effect, suggesting that physiological concentrations of progesterone promoted the cell surface expression of Tim-3. However, estradiol and b-hCG did not affect Tim-3 abundance on NK cells ( fig. S3 ). Together, these data suggest that the abundance of Tim-3 on pNK cells increased during early pregnancy through IL-4-STAT6 or progesterone signaling.
Gal-9-Tim-3 interactions induce the immunosuppressive activity of NK cells in maternal blood Previous studies indicated that the immunoregulatory effect of Tim-3 depends on the interaction with its ligand, Gal-9 (21, 33, 34) . Thus, we treated pNK cells with recombinant human Gal-9 (rhGal-9) and detected substantial increases in the amounts of TGF-b1 and IL-10 produced by pNK cells but a decreased amount of TNF-a production (Fig. 2E) . The activity of rhGal-9 was dependent on Tim-3, because an anti-Tim-3 neutralizing antibody blocked rhGal-9 activity, whereas a neutralizing antibody against CD44, another target receptor for Gal-9, failed to abrogate the effect of rhGal-9 on NK cells (Fig. 2E) . Similarly, rhGal-9 suppressed the production of perforin (Fig. 2E ) and inhibited pNK cytotoxicity (Fig. 2F) , and these effects were abrogated by the anti-Tim-3 antibody but not the anti-CD44 antibody. Therefore, these data suggest that Gal-9 might modulate pNK cell function toward an immune tolerant state by binding Tim-3.
To identify the signaling pathways downstream of Gal-9-Tim-3, we stimulated pNK cells with rhGal-9 and examined the phosphorylation of key kinases involved in NK cell function. We found that rhGal-9 substantially increased the abundances of total AKT and phosphorylated AKT (pAKT), as well as of phosphorylated c-Jun N-terminal kinase (pJNK) and phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) (Fig. 2G) . Furthermore, the specific inhibition of the JNK or AKT signaling pathways, but not ERK1/2 signaling, eliminated the effect of rhGal-9 on pNK cells (Fig. 2H) . These results suggest that the Gal-9-Tim-3 interaction may induce a tolerant phenotype in pNK cells through the activation of JNK and AKT signaling. In addition to these downstream signaling molecules, we also analyzed the expression of genes encoding transcription factors that are associated with NK cell development. After rhGal-9 stimulation, the abundances of mRNAs of ID2, BLIMP1, and GATA3 were substantially increased, whereas that of EOMES was markedly reduced (Fig. 2I) . Similar results were found at the protein level (Fig. 2J) . The altered expression of ID2, BLIMP1, GATA3, and EOMES induced by rhGal-9 was abrogated by the specific inhibition of JNK or AKT (Fig. 2K ). All ex vivo analyses suggested a Gal-9-dependent mechanism, whereby Tim-3 inhibits pNK cell activity. between patients with RM and those control donors with NPs, the cell surface abundance of Tim-3 [as assessed by measurement of the mean fluorescence intensity (MFI)] on pNK cells was substantially decreased in patients with RM (Fig. 3A) . Furthermore, the plasma Gal-9 concentration ( Fig. 3B ) and the amount of intracellular Gal-9 produced in peripheral immune cells (Fig. 3C) Data are means ± SEM of four experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 by ANOVA.
(G) NK cells were stimulated with rhGal-9 for the indicated times before being analyzed by Western blotting with antibodies against the indicated proteins. Bar graphs show pooled densitometric data from three experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 by Student's t test. pNF-kB, phosphorylated nuclear factor kB; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NS, not significant. (H) Purified NK cells were stimulated with rhGal-9 in 15 mM LY294002, 10 mM SP600125, 10 mM U0126, or DMSO, as indicated. The cells were analyzed by flow cytometry to determine the percentage of cells positive for the indicated cytokines or perforin. Data are means ± SEM of 10 experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by ANOVA.
(I and J) NK cells were left unstimulated or were stimulated with rhGal-9 for 48 hours and then analyzed by real-time PCR to determine the relative abundances of the indicated mRNAs (I) and by Western blotting with antibodies against the indicated proteins (J). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by Student's t test. (K) NK cells were left untreated or treated with rhGal-9 in the presence or absence of the indicated inhibitors. The relative abundances of the indicated mRNAs were then determined by real-time PCR analysis. Data in (I) to (K) are means ± SEM of three experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 by ANOVA.
including TNF-a and IFN-g, as well as more perforin (Fig. 3D ). The cytotoxicity of Tim-3 + pNK cells from patients with RM was also enhanced (Fig. 3E ), suggesting that there were functional defects in the Tim-3 + NK cells of patients with RM. However, cytokine production by the Tim-3
− NK cells and their cytotoxicity were comparable between RM patients and donors with NPs (Fig. 3, D and E) . Accordingly, the immunosuppressive activity of Tim-3 + NK cells was markedly reduced in patients with RM, which may account for the uncontrolled allogeneic response to the fetus.
Chromatin accessibility of genes encoding anti-and pro-inflammatory cytokines is altered in Tim-3 + NK cells from patients with RM To systemically characterize the difference in Tim-3 + pNK cells between RM patients and donors with NPs, we assessed the landscape of chromatin accessibility in their Tim-3 + and Tim-3 − NK cells. An assay for transposase-accessible chromatin sequencing (ATAC-seq) was used to analyze global chromatin accessibility (35) . To determine whether global chromatin accessibility reflected the differences among samples, we performed a principal components analysis (PCA). We found that the samples formed three well-separated groups, including Tim-3 + NK cells from RM patients, Tim-3 − NK cells from RM patients, and NK cells (either Tim-3 + or Tim-3 − ) from normal donors (Fig. 4A) . PC1, which accounted for 50% of the total variance, separated the Tim-3 + cells from the Tim-3 − NK cells of RM patients. PC2, which accounted for 15% of the variance, distinguished the NK cells of normal donors from those of RM patients (Fig. 4A ). Note that the NK cell subsets from the same normal donor tended to cluster together, suggesting that individual differences overshadowed the differences between Tim-3 + and Tim-3 − cells in normal donors. Similarly, hierarchical clustering confirmed the separation between patient NK cells and normal donor NK cells (Fig. 4B ). These results suggest that the chromatin accessibility of pNK cells can capture different pregnancy outcomes. Thus, these findings suggest that Tim-3 + pNK cells represent an indicator of pregnancy status, which prompted our desire to investigate the underlying mechanism by which Tim-3 + NK cells are involved in gestation.
We next compared the Tim-3 + NK cells from RM patients to those from normal donors and identified 260 regions with statistically significantly reduced accessibility but 360 regions with significantly increased accessibility in the cells from the RM patients (P < 0.05) (Fig. 4C ). On the basis of published chromatin immunoprecipitation sequencing (ChIP-seq) results for human CD56 + NK cells, the regions with reduced accessibility in the RM patients were associated with H3K4me1 hi H3K4me3 low (the two forms of methylation of Lys 4 on histone H3) histone modifications and were distal to transcription start sites (TSSs), suggesting that these regions were mainly enhancers. In contrast, regions with increased accessibility in the RM patient cells were enriched for H3K4me1 low H3K4m3 hi and were proximal to the TSS, suggesting that they were mainly promoters (Fig. 4, D and E) . These data suggest that promoters and enhancers were regulated by different mechanisms in Tim-3 + NK cells. Furthermore, one of the regions with the most diminished accessibility in the Tim-3 + NK cells from RM patients was the 3′ end of the TGFB1 gene, which was associated with a reduced promoter accessibility are means ± SEM of nine donors per group. *P < 0.05, **P < 0.01, and ***P < 0.001 by Student's t test.
of TGFB1, suggesting that this region functions as an enhancer to coordinate with the TGFB1 promoter (Fig. 4, C and F ). This enhancer in the Tim-3 − NK cells from RM patients showed a similar accessibility to that of the enhancer in Tim-3 − NK cells from normal donors, suggesting that a cell-specific mechanism regulates TGFB1 expression in Tim-3 + NK cells (Fig. 4F) . Similarly, the accessibility of the IL10 locus was also reduced in the Tim-3 + NK cells from RM patients (Fig. 4G ). These data suggest that Tim-3 activation in NK cells during pregnancy promotes the accessibility of loci encoding anti-inflammatory cytokines, which enhances their expression and induces immune tolerance to the fetus. A decreased expression of Tim-3, together with other defects, may inhibit the accessibility of these genes encoding anti-inflammatory cytokines in RM patients and contribute to immune-based rejection of the fetus.
Chromatin-accessible regions are usually associated with histone acetylation, which is recognized by bromodomain-containing proteins and RM patients were treated with the indicated concentrations of JQ1, and the percentages of the NK cells that were positive for TNF-a (left) and IFN-g (right) were determined by flow cytometry. Data are means ± SEM of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 by Student' s t test.
(36). To investigate the relationship between altered chromatin accessibility and cytokine-encoding gene expression, we treated the Tim-3 + or Tim-3 − NK cells with JQ1, an inhibitor of the BET family of bromodomain proteins (37) . We observed that the percentages of Tim-3 + NK cells from RM patients that were positive for the inflammatory cytokines TNF-a and IFN-g were substantially reduced by JQ1 (Fig. 4H) . Treatment with JQ1 also reduced the percentages of Tim-3 − NK cells from RM patients with normal donors that were positive for TNF-a and IFN-g, although to a lesser degree. Furthermore, JQ1 had no effect on the percentages of Tim-3 + NK cells from normal donors that were positive for inflammatory cytokines (Fig. 4H) . The production of TGFb1 and perforin was unaffected by JQ1 ( fig. S4 ). These data suggest that the increased pro-inflammatory cytokine production by Tim-3 + NK cells from patients with RM was at least partially caused by the increased accessibility of the loci of the corresponding genes.
Tim-3 + NK cells from RM patients are less potent than those from normal donors in promoting iT reg differentiation TGF-b1 is a key factor in inducing the differentiation of naïve CD4 + T cells to iT regs . Our earlier results (Figs. 3D and 4, C and F) showed that the Tim-3 + NK cells from normal donors produced large amounts of TGF-b1 compared to those from RM patients, which also showed the most diminished promoter accessibility of TGFB1. Therefore, we hypothesized that Tim-3 + NK cells could promote the generation of iT regs and that this activity of Tim-3 + NK cells might be impaired in patients with RM, which could contribute to the pathogenic role of this NK cell population in RM.
To investigate this hypothesis, we first cultured Tim- + T cells, and this was inhibited by an anti-TGF-b1 neutralizing antibody (Fig. 5A) . The production of TGF-b1 in the iT regs was also promoted by Tim-3 + NK cells (Fig. 5B) . In addition, we investigated the in vitro capacity of the iT regs that were induced by Tim (Fig. 5C ). IFN-g production by the CD4 + CD25
− T cells was also reduced by pT regs and iT regs (Fig. 5D) . These results suggest that Tim-3 + NK cells not only induce the differentiation of iT regs but also promote their immunosuppressive function in a TGF-b1-dependent manner.
We next compared Tim-3 + NK cells from RM patients and matched controls for their capacity to induce the differentiation of CD4 + CD45RA + naïve T cells into T regs . In coculture experiments with naïve CD4 + T cells, Tim-3 + NK cells from RM patients were less capable than control cells to induce Foxp3 + T cell generation (Fig. 5, E and F) . Using a crossover approach to compare the effect of Tim-3 + NK cells derived from RM patients and from controls on T reg differentiation and function, we found that the percentage of Foxp3 + and TGF-b1 + cells induced by RM patient Tim-3 + NK cells was substantially less than that induced by control Tim-3 + NK cells (Fig. 5G) . This is consistent with our observation that Tim-3 + NK cells from RM patients produce less TGF-b1 compared with those from controls. From these results, we conclude that Tim-3 + NK cells in maternal peripheral blood can promote iT reg differentiation and enhance iT reg function through TGF-b1 but that this capacity is attenuated in RM patients.
Tim-3 blockade disrupts immune tolerance and induces pregnancy failure
To further explore the function of Tim-3 in pregnancy, we used a wellestablished AP mouse model (38, 39) . Consistent with observations in human pregnancies, the percentage of Tim-3 + NK cells in the first trimester of pregnancy was substantially greater than in the second trimester in mice ( fig. S5A ). In addition, in the AP mice, the abundances of Tim-3 and Gal-9 on NK cells were decreased ( fig. S5B) , which was accompanied by abnormal cytokine production and cytotoxicity ( fig. S5,  C and D) . The conserved function of Tim-3 + NK cells between humans and mice further highlights the importance of the Tim-3 signaling in the immunoregulation of NK cells during pregnancy.
We next treated the AP and NP mice with a Tim-3-blocking antibody, RMT3-23. This antibody substantially decreased litter size and increased the resorption rate in NP and AP mice (Fig.  6, A to C) . The fetus size for mice treated with RMT3-23 was also markedly decreased (Fig. 6, D and E) , suggesting that Tim-3 blockade had an adverse effect on embryo development. In addition, we found that the NK cell number in peripheral blood declined markedly ( fig. S6A ) in mice treated with RMT3-23. Flow cytometric analysis showed that the greatest abundance of Tim-3 was on mature CD11b single-positive (SP) cells but that the lowest abundance of Tim-3 was on immature CD27 SP cells ( fig. S6 , B and C). Moreover, Tim-3 abundance was gradually increased during the process of NK cell differentiation from CD34 + cells to mature NK cells ( fig. S6D ). Together, these data suggest that Tim-3 is closely associated with NK cell development and maturation. Furthermore, Tim-3 blockade inhibited the production of anti-inflammatory cytokines but promoted pro-inflammatory cytokine production by the splenic NK cells in both NP and AP mice (Fig. 6F) . Similar results were obtained in dNK cells (fig. S7A ). However, we observed that activating Tim-3 by administering recombinant mouse Gal-9 (rmGal-9) reduced embryo resorption in AP mice but not in normal mice (Fig. 6,  A and D) . The RMT3-23-induced fetal loss in both NP and AP mice was not reversed by rmGal-9 administration (Fig. 6, A and C) . Consistent results were obtained for cytokine production and the cytotoxicity of NK cells in the spleen (Fig. 6F) and decidua (fig. S7A ). These observations suggest a possible role for Gal-9 and Tim-3 signaling in the regulation of the immune tolerant propensity of NK cells in pregnancy.
To assess the signaling pathways downstream of Gal-9 and Tim-3, the relative abundances of pJNK and pAKT were measured by performing intracellular staining. The inhibitory effect of RMT3-23 on JNK and AKT phosphorylation in NK cells was observed, and the administration of rmGal-9 failed to reverse that inhibitory effect. However, we detected substantial JNK and AKT phosphorylation in NK cells from mice treated with rmGal-9 (Fig. 6G) . Furthermore, NK cells from RMT3-23-challenged mice had decreased amounts of the transcriptional regulators Id2, Blimp-1, and Gata-3 but an increased amount of Eomes compared to NK cells from control mice. Conversely, NK cells from mice treated with rmGal-9 exhibited increased amounts of Id2, Blimp-1, and Gata-3 but a decreased amount of Eomes (Fig.  6H) . Consistent results were observed in the decidua (fig. S7 , B and C). Thus, the regulatory effect of Tim-3 and Gal-9 on NK cells during pregnancy might depend on the JNK and AKT signaling pathways and might be mediated through the modulation of the transcription factors Id2, Blimp-1, Gata-3, and Eomes.
The in vitro experiments revealed that Tim-3 + NK cells can induce T reg generation. Here, our in vivo studies showed that interfering with the Tim-3-Gal-9 interaction notably affected the phenotype and function of NK cells from pregnant mice. Next, we wondered whether the T regs would show some consistent changes. Our results showed that the proportions of CD25 + Foxp3 + T regs in blood and spleen were reduced in mice treated with RMT3-23 compared to those in untreated mice (Fig. 6, I and J). Consistent with this observation, these T regs displayed an impaired immunosuppressive capacity and reduced TGFb1 production (Fig. 6, I and J) . Furthermore, the administration of rmGal-9 led to an increase in the proportion of CD25 +
Foxp3
+ T regs with enhanced TGF-b1 production in the blood and spleen (Fig. 6, I and J). Consistent results were observed in the decidua (fig. S7D ). These data suggest that the Tim-3-Gal-9 signaling pathway facilitates the immunosuppressive activity of NK cells and the induction of T regs during pregnancy. (Fig. 7A) . We observed that the resorption rates of mice that received Tim-3 + NK cells and total NK cells from the mice with NP were substantially reduced. The adoptive transfer of Tim-3 − NK cells from mice with NP had no obvious effects on the resorption rate. In contrast, Tim-3 + NK cells and total NK cells isolated from the AP mice failed to reverse the pregnancy outcome (Fig. 7 , B and C). In addition, the effect of Tim-3 + NK cells from AP mice was rescued after treatment with IL-4 or progesterone, which was concomitant with the increased Tim-3 abundance on the treated cells (Fig. 7, B to D) . Furthermore, we found a marked increase in the proportion of CD25 + Foxp3 + T regs in the blood of AP mice that received Tim-3 + NK cells and total NK cells from mice with NP (Fig. 7E) . The transfer of Tim-3 + NK cells and total NK cells from the AP mice had no effect on the proportion of + T regs in the blood of the recipient mice (Fig. 7E) in NK cells (40) , Nfil3 −/− pregnant mice display an increased rate of embryo resorption than do the control mice. We sorted Tim-3 + and Tim-3 − NK cells from the spleens of Nfil3 +/+ mice (which have NP) and injected them into Nfil3 −/− pregnant mice. The adoptive transfer of Tim-3 + NK cells, but not Tim-3 − NK cells, substantially reduced the embryo resorption rate of the recipient Nfil3 −/− mice (Fig. 7, F  and G) . Furthermore, we found that the proportion of CD25 + Foxp3 + T regs was increased in the blood and spleen of Nfil3 −/− mice that received Tim-3 + NK cells. The production of TGF-b1 by the CD25 + Foxp3 + T regs was also substantially greater than that in the mice that received Tim-3 − NK cells. The transfer of Tim-3 − NK cells had no effect on the proportion of CD25 +
+ T regs or their production of TGF-b1 (Fig. 7H) . Consistent results were observed in the decidua (fig. S8, F and G) . These data suggest that Tim-3 + NK cells with the capacity to induce T reg differentiation contribute to immune tolerance and pregnancy maintenance.
DISCUSSION
NK cells are crucial in the establishment and maintenance of pregnancy because of their functional diversity, including their roles in placental vascular remodeling and immunoregulation. Emerging evidence indicates an association between the abnormality of NK cells and the occurrence of RM. A meta-analysis showed that women with RM have statistically significantly more pNK cells than those with a healthy pregnancy (7, 20) . For patients with a history of RM, the increased activity of pNK cells might be predictive of subsequent miscarriage. In addition, cytokine production by pNK cells is dysregulated in women with a history of reproductive failure (41) . These studies suggest that women with RM have altered pNK parameters, which can therefore be recommended as biological markers to identify RM and assess the effect of immunotherapy. However, the specific role of pNK cells in pregnancy is poorly defined, and little is known about the underlying molecular mechanism. Here, we described Tim-3 + NK cells with tolerance phenotypes that are characterized by an increased production of anti-inflammatory cytokines (including TGF-b1, IL-10, and IL-4), a reduced production of proinflammatory cytokines (including TNF-a), and reduced cytotoxicity toward trophoblast cells. Furthermore, this subtype of NK cells efficiently induced T reg differentiation. These results suggest that Tim-3 + pNK cells can directly contribute to the anti-inflammatory microenvironment and, more selectively, facilitate iT reg proliferation, which is conducive to maternal-fetal immune tolerance.
The systemic generation of T regs during early gestation is pivotal for successful pregnancy in both human and mouse models. The importance of T regs for NP has been demonstrated in studies showing that the absence of T regs can impair murine pregnancy, whereas the adoptive transfer of T regs can prevent fetal rejection (42, 43) . However, the mechanism underlying T reg generation during early pregnancy is unclear. Here, we found that the accessibility of TGFB1 in Tim-3 + pNK cells from patients with RM was reduced, resulting in a marked decrease in the production of TGF-b1 and a subsequent deficiency in T reg differentiation. Thus, our results suggest that previous reports of diminished T reg responses in patients with RM may be attributable to abnormal Tim-3 + NK cells. These findings provide new insights into the mechanism of RM and the versatility of NK cells (44) .
We found that Tim-3 abundance on pNK cells was decreased in patients with RM, indicating that Tim-3 + NK might be a predictor of aberrant pregnancy. However, the regulation of Tim-3 abundance on NK cells is unclear. Here, we found that the amount of cell surface Tim-3 on pNK cells was increased during the first trimester in NP because of the typical T H 2 polarization signaling by the IL-4-STAT6 pathway and physiological concentrations of progesterone. However, increased concentrations of progesterone showed an inhibitory effect on Tim-3 abundance, which may explain the decreased abundance of Tim-3 on NK cells in the second trimester of pregnancy, when the progesterone concentration is several times greater than that in early pregnancy. Estrogen and b-hCG showed no effect on Tim-3 abundance on pNK cells, which is consistent with the wide use of progesterone, but not estrogen or b-hCG, in the clinical treatment of early threatened abortion. Moreover, progesterone promotes T H 2 responses by inhibiting T H 1 cytokine production (45, 46) . Thus, we suggest that progesterone induces Tim-3 abundance on pNK cells through a direct effect as well as an indirect effect by regulating the T H 2-T H 1 balance. This result provides a potential theoretical basis for the clinical application of progesterone in the treatment of RM.
Accompanying the deficient Tim-3 expression on pNK cells in RM, we found a substantial decrease in the concentration of the natural ligand Gal-9 in the blood circulation. Furthermore, rmGal-9 administration reduced embryo resorption in AP mice, and the disordered cytokine production of NK cells was efficiently reversed, consistent with the results of our in vitro experiment. We therefore propose that the Tim-3-mediated immunomodulation by pNK cells during pregnancy is enhanced by Gal-9. In addition, Gal-9-Tim-3 activated JNK and AKT, leading to increased ID2, BLIMP1, and GATA3 mRNA abundance and decreased EOMES mRNA abundance. These transcription factors are associated with NK cell development and functions (47) (48) (49) . Previous reports demonstrated that Tim-3 ligation enhances the activation of the MAPK (mitogen-activated protein kinase) and NF-kB pathways (50) . Tim-3 enhances phosphoinositide 3-kinase (PI3K)-AKT activation and A20 activity, inhibiting Toll-like receptor 4 (TLR4)-stimulated NF-kB activation (51) . Nevertheless, we showed that JNK and AKT were downstream mediators of Gal-9-Tim-3 signaling. Differences among these studies might be explained by the specific intracellular tail of Tim-3 found in different cell types (50, 52) . Thereby, the influence of Gal-9 on pregnancy outcome and the underlying mechanism of its interaction with Tim-3 indicate its potential application in the diagnosis and treatment of RM.
We also showed that Tim-3 blockade substantially increased embryo resorption and led to the appearance of dysfunctional pNK cells, further confirming the crucial modulatory effects of Gal-9-Tim-3 on pNK cells in pregnancy. Note that blocking Tim-3 decreased pNK cell numbers ( fig. S6A) , which is consistent with Tim-3 activation by Gal-9 inducing the expression of genes encoding transcription factors associated with NK development. To find the mechanism underlying the decrease in the number of pNK cells after RMT3-23 treatment, we analyzed the expression of Tim-3 on CD27 The results showed that the greatest abundance of Tim-3 was on mature CD11b SP cells but that the lowest abundance of Tim-3 was on immature CD27 SP cells ( fig. S6, B and C) . Consistently, flow cytometric analysis of human samples showed that about 80% of mature CD56
dim NK cells had cell surface Tim-3, whereas only about 40% immature CD56 bright NK cells were Tim-3 + (Fig. 1C) . These data imply that Tim-3 might be associated with NK cell development and maturation. Moreover, we analyzed the published microarray data (28) and found that Tim-3 expression was gradually increased during the process of NK cell differentiation from CD34 + cells to mature NK cells (fig. S6D ). In addition, Ndhlovu et al. (28) S6 , B and C), RMT-23 led to a marked reduction in the number of pNK cells. On the basis of these results, we suggest that Gal-9-Tim-3 signaling not only regulates pNK cell function but also influences pNK cell development.
In conclusion, we identified a distinct NK cell subpopulation, Tim-3 + NK cells, with immunosuppressive activity in early pregnancy ( fig. S9 ).
The reduced abundance of Tim-3 on NK cells was accompanied by disordered anti-and pro-inflammatory cytokine profiles in patients with RM. Moreover, the T reg differentiation-inducing activity of Tim-3 + NK cells was attenuated in patients with RM. Together, these results suggest a protective role for this NK cell subset in pregnancy. Currently, the most commonly used biomarkers (serum hCG and progesterone) are regarded as ineffective in predicting pregnancy outcome (7) . Thus, an accurate and reliable diagnostic biomarker is urgently needed to reflect the maternal-fetal tolerance status and to enable preventative intervention. The Tim-3 + NK cells defined in our study may serve as biological markers during early pregnancy for predicting the occurrence of RM. Our findings also underscore the important functional diversity that exists within human NK cell subpopulations and provide insights into the molecular mechanisms by which NK cells mediate immune tolerance. Because the embryo expresses paternal antigens foreign to the mother, it has been regarded as an allograft or a pseudotumor. Paradigms from our study may also be useful for investigating transplantation immunology and tumor immunology.
MATERIALS AND METHODS
Human sample collection
This study was approved by the Research Ethics Committee of Obstetrics and Gynecology Hospital, Fudan University (Shanghai, China). All subjects signed informed written consent for the collection and study of samples. Peripheral blood samples were obtained from normal nonpregnant women, women with clinically normal pregnancy, and patients with RM that occurred during the first trimester. NPs were terminated for nonmedical reasons, and RMs were classified as unexplained after the exclusion of maternal anatomic or hormonal abnormalities or paternal and maternal chromosomal defects.
Flow cytometry and cell sorting Cells were washed and incubated with appropriate fluorochromeconjugated antibodies for staining. Flow cytometric analysis was performed on a CyAn ADP analyzer (Beckman Coulter), and data were analyzed with FlowJo version 6.1 software (Tree Star). For flow cytometric sorting, cells were stained with specific antibodies and isolated on a BD FACSAria cell sorter (BD Biosciences).
Western blotting analysis
Whole-cell protein extracts were prepared by lysing cells in radioimmunoprecipitation assay buffer supplemented with proteinase inhibitors and phosphatase inhibitors (Beyotime Institute of Biotechnology). Protein yield was quantified using the bicinchoninic acid protein assay. After denaturation, equal amounts of protein were separated by SDSpolyacrylamide gel electrophoresis before wet-transfer onto polyvinylidene difluoride membranes (Amersham Biosciences). Nonspecific binding sites were blocked by incubating the membranes with 5% bovine serum albumin (BSA) in tris-buffered saline (TBS) with 0.1% Tween 20 (TBS-T) for 1 hour, which were rinsed and incubated with primary antibody solutions (1:500 , pp38, pAKT, ERK1/2, NF-kB p65, JNK, p38, and AKT; and 1:3500 for GAPDH) diluted in blocking buffer (5% BSA and 1× TBS-T) overnight at 4°C. All of the antibodies used for Western blotting analysis were purchased from Cell Signaling Technology. Primary antibodies were removed by washing the membranes four times in TBS-T, and the membranes were then incubated for 1 hour with horseradish peroxidase-conjugated secondary antibody (1:5000). After three washes with TBS-T, immunopositive bands on the blots were visualized with the enhanced chemiluminescence detection system (Merck Millipore). Murine models of pregnancy Male DBA/2 and female CBA/J mice (8 to 10 weeks old) were purchased from Beijing HFK Bioscience Co. Male Balb/c mice (8 to 10 weeks old) were purchased from the Department of Laboratory Animal Science, Fudan University. All animals were kept under specific pathogen-free conditions. All of the experimental procedures involving animals were conducted in accordance with the Guide for the Care and Use of Laboratory Animals (China), and permission was approved by the Human Research Ethics Committee of Obstetrics and Gynecology Hospital of Fudan University. CBA/J × Balb/c mating combinations (NP model) were established as follows: female CBA/J mice were mated in natural cycling with male Balb/c mice. CBA/J × DBA/2 mating combinations (AP model) were established as follows: female CBA/J mice were mated in natural cycling with male DBA/2 mice. Detection of a vaginal plug was chosen to indicate day 0.5 of gestation. Pregnant females received three injections of RMT3-23 (anti-Tim-3 antibody) intraperitoneally at doses of 500, 250, and 250 mg at days 3.5, 5.5, and 7.5, respectively. In other instances, pregnant mice were injected with rmGal-9 intraperitoneally at a dose of 100 mg at days 3.5, 5.5, and 7.5, respectively. The percentage of resorbed embryos was calculated as follows: resorbed embryos/total embryos × 100. −/− mice (a gift from H. Wei, University of Science and Technology of China). The same volume of PBS was injected into the control mice. All of the recipient mice were sacrificed and examined to calculate the embryo resorption rate.
Expression profiling by microarray Tim-3 + pNK cells and Tim-3 − pNK cells from six women with NP were sorted by FACS. Total RNA was directly isolated with TRIzol according to the manufacturer's instructions. RNA was analyzed on a NanoDrop spectrophotometer (Thermo Fisher Scientific) and a Bioanalyzer (Agilent) to determine RNA yield and integrity. RNA was subjected to one round of amplification and biotinylation with the Amino Allyl MessageAmp II aRNA Amplification Kit (Thermo Fisher Scientific). Biotinylated RNA was hybridized to human genome HOA 6.2 chips. Gene expression analysis was performed using the Whole Genome OneArray Microarray (Phalanx Biotech Group). The log 2 ratio of each probe was calculated by pairwise combination and error-weighted average. Probes showing a log 2 ratio of ≥1 or ≤−1 and a P value of <0.05 were defined as differentially expressed genes.
Assay for transposase-accessible chromatin sequencing The ATAC-seq protocol (35, 53) was performed to profile open chromatin. The ATAC-seq libraries were sequenced on a HiSeq 2500 next-generation sequencer (Illumina) with paired-end 50-bp reads. The ATAC-seq reads were mapped to Hg19 with Bowtie2, and mitochondrial or duplicate PCRs were removed. ATAC-seq peaks were identified with MACS2, and peaks from all of the samples were merged with Homer. The number of reads falling into each peak was then calculated with Homer, and differentially accessible regions were determined with DESeq2 (P < 0.05).
Statistical analysis
The statistical software Prism 6 (GraphPad) was used for data analyses. Statistical significance was determined by Student's t test. Multiple means were compared by ANOVA. Error bars in figures indicate the SEM. Statistical significance was set at P < 0.05. Statistically significant results are expressed using asterisks, where *P < 0.05, **P < 0.01, and ***P < 0.001.
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www.sciencesignaling.org/cgi/content/full/10/498/eaah4323/DC1 Fig. S1 . Detection of Tim-3 on different cell types in the peripheral blood of patients in early pregnancy. Fig. S2 . GO analysis of differentially expressed genes. Fig. S3 . Estrogen and b-hCG have no effect on Tim-3 abundance on pNK cells. 
